Vai al contenuto principale della pagina

FDA user fees 2012 : issues related to accelerated approval, medical gas, antibiotic development, and downstream pharmaceutical supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, March 8, 2012



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Titolo: FDA user fees 2012 : issues related to accelerated approval, medical gas, antibiotic development, and downstream pharmaceutical supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, March 8, 2012 Visualizza cluster
Pubblicazione: Washington : , : U.S. Government Printing Office, , 2013
Descrizione fisica: 1 online resource (iv, 214 pages) : illustrations
Soggetto topico: Drug approval - United States
Gases - Therapeutic use - Government policy - United States
Antibiotics - Development - United States
Drugs - United States - Marketing
Note generali: Title from title screen (viewed on Aug. 21, 2013).
Paper version available for sale by the Superintendent of Documents, U.S. Government Printing Office.
"Serial no. 112-126."
Nota di bibliografia: Includes bibliographical references.
Altri titoli varianti: FDA user fees 2012
Titolo autorizzato: FDA user fees 2012  Visualizza cluster
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910704708903321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui